Drugs Made In America Acquisition II Corp. (DMII) Stock Profile — Insider Trades & Financials

Net Income-$143.6K

Market Cap$654.4M

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

Roger Bendelac

CEO & Executive Director

Drugs Made In America Acquisition II Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2024 and is based in Fort Lauderdale, Florida.

Founded: 2024
Headquarters: Fort Lauderdale, Florida, United States

Peer ComparisonRevenue ($B)

▾

⚡

Core Efficiency

ROE?

0.83%

ROA?

-0.03%

D/E Ratio?

-1.05

📊

Profitability Ratios

Current Ratio?

1.32

Loading comparison...

Earnings Calendar

Filing history and next expected filing date

Next Expected Filing

Mar 30, 2026 (8 days ago)

Quarterly Report (10-Q) — Estimated

Mar 30, 2026

Predicted10-Q

Nov 18, 2025

10-QQ3 20250d after period end

Data Freshness

Financial Data

2 days ago

Latest filing: 2025-11-18

SEC Metadata

16 days ago

Latest filing: 2025-11-18

Loading company sections...